Faber Logo Skip to main content

Our Clients

We have worked with over 2000 companies, investors and research institutions.

All clients, by client group

  • Alliance Foundation Trials, LLC
  • Bluefield Project to Cure FTD
  • Children's Urological Foundation
  • Commonwealth Cancer Consortium (Break Through Cancer)
  • Cure GM1 Foundation
  • Foundation for Angelman Syndrome Therapeutics (FAST)
  • Global Alliance for TB Drug Development
  • The N=1 Collaborative, Inc.
  • Tufts University
Learn more about our work in this industry

  • ActNano, Inc.
  • Ambulomics, Inc.
  • Biobot Analytics, Inc.
  • Breathe BioMedical Inc. (Canada)
  • CAMP4 Therapeutics, Inc.
  • Day Zero Diagnostics, Inc.
  • Dialco Medical Inc.
  • GelMEDIX, Inc.
  • HighRes Biosolutions, Inc.
  • Instylla, Inc.
  • JC Medical, Inc.
  • Moximed, Inc.
  • Palette Life Sciences AB
  • PolarSeal Tapes & Conversions Ltd.
  • Polypeptide Therapeutic Solutions US - Curapath
  • Reveal Pharmaceuticals, Inc.
  • SAGA Dx, Inc.
  • Salmoss SpA
  • Savran Technologies Inc.
  • Sirtex Technology Pty Ltd
  • Spectral Medical Inc.
  • Tides Medical, LLC
  • Vizgen, Inc.
Learn more about our work in this industry

  • Abata Therapeutics, Inc.
  • Abcentra LLC
  • Accent Therapeutics, Inc.
  • Actithera, Inc.
  • Adrenas Therapeutics, Inc.
  • Aerium Therapeutics, Inc.
  • Affini-T Therapeutics, Inc.
  • Affinia Therapeutics, Inc.
  • Akebia Therapeutics, Inc.
  • Aktis Oncology, Inc.
  • Aldeyra Therapeutics, Inc.
  • Aliada Therapeutics, Inc.
  • Allorion Therapeutics Inc.
  • Alltrna, Inc.
  • Allyx Therapeutics, Inc.
  • Alnylam Pharmaceuticals, Inc.
  • Alpheus Medical, Inc.
  • Ananda Scientific, Inc.
  • Angiex, Inc.
  • Anokion US, Inc.
  • Anthos Therapeutics, Inc.
  • Antidote Therapeutics, Inc.
  • Apic Bio, Inc.
  • Apollo Therapeutics Limited
  • Arbor Biotechnologies, Inc.
  • Arcadia Science LLC
  • Artax Biopharma, Inc.
  • ARTBIO Inc.
  • AS2 Bio Inc.
  • AsclepiX Therapeutics, Inc.
  • Aspa Therapeutics, Inc.
  • Astria Therapeutics, Inc.
  • Atavistik Bio
  • Atomwise Inc.
  • aTyr Pharma, Inc.
  • Aura Biosciences, Inc.
  • Auron Therapeutics, Inc.
  • AvenCell Therapeutics, Inc.
  • Avenzo Therapeutics, Inc.
  • Axial Therapeutics, Inc.
  • Betagenon AB
  • Bicara Therapeutics Inc.
  • Bill & Melinda Gates Foundation and the Bill & Melinda Gates Medical Research Institute
  • Blue Oak Pharmaceuticals, Inc.
  • Cambrian BioPharma, Inc.
  • Carbon Biosciences, Inc.
  • Cardurion Pharmaceuticals, Inc.
  • CG Pharmaceuticals, Inc.
  • Chordia Therapeutics, Inc.
  • Chrysalis Genetics Inc.
  • Claris Biotherapeutics, Inc.
  • Cloverleaf Bio, Inc.
  • Cora Biosciences, Inc.
  • Corner Therapeutics, Inc.
  • Cyteir Therapeutics, Inc.
  • Deciphera Pharmaceuticals, LLC
  • Delphia Therapeutics, Inc.
  • DEM BioPharma, Inc.
  • DG Medicines, Inc.
  • Dianthus Therapeutics OpCo, Inc.
  • Dicerna Pharmaceuticals, Inc.
  • Diceros Therapeutics, Inc.
  • Disc Medicine, Inc.
  • Dispatch Biotherapeutics, Inc.
  • Domain Therapeutics USA, Inc.
  • Doppler Bio, Inc.
  • Eicosis LLC
  • Elevian, Inc.
  • Elicio Therapeutics, Inc.
  • Emerald Lake Safety LLC
  • Epalex Corporation
  • Epibiologics, Inc.
  • Ernest Pharmaceuticals, LLC
  • EvolveImmune Therapeutics, Inc.
  • Expansion Therapeutics, Inc.
  • Forma Therapeutics, Inc.
  • General Oncology, Inc.
  • Ghrelco, Inc.
  • GV.M1 Inc.
  • GV20 Therapeutics LLC
  • hC Bioscience, Inc.
  • Helix Nanotechnologies, Inc.
  • Hemab ApS
  • HilleVax, Inc
  • Hillstar Bio, Inc.
  • HUTCHMED Limited
  • Hyku Biosciences, Inc.
  • IDBiologics, Inc.
  • IDEAYA Biosciences, Inc.
  • Ikena Oncology, Inc.
  • Immunocodex, Inc.
  • ImmunoGen, Inc.
  • InflaRx Pharmaceuticals, Inc.
  • Jumble Therapeutics, Inc.
  • Kanyos Bio, Inc.
  • Karuna Therapeutics, Inc.
  • Kelonia Therapeutics, Inc.
  • Korro Bio, Inc
  • KSQ Therapeutics, Inc.
  • Launchpad Therapeutics, Inc.
  • Lightship Scientific Consulting, LLC
  • Linden Lake Labs
  • Lumen Bioscience, Inc.
  • Lyra Therapeutics, Inc.
  • Macrotope, Inc.
  • Magnet Biomedicine, Inc.
  • Mahzi Therapeutics
  • Mariana Oncology
  • Merlin Therapeutics, Inc.
  • Mnemo Therapeutics SAS
  • Modal Therapeutics, Inc.
  • Myeloid Therapeutics, Inc.
  • Neurogastrx, Inc.
  • NextPoint Therapeutics, Inc.
  • NextRNA Therapeutics, Inc.
  • Normunity AccelCo, Inc.
  • Normunity, Inc.
  • NorthSea Therapeutics, B.V.
  • Novo Nordisk A/S
  • Nucyrna Therapeutics, Inc.
  • Nurix Therapeutics, Inc.
  • Obsidian Therapeutics, Inc.
  • Okava Pharmaceuticals, Inc.
  • Olaris Inc.
  • Oligomerix, Inc.
  • OneCyte Biotechnologies, Inc.
  • ONK Therapeutics Limited
  • Onsero Therapeutics Inc
  • Orna Therapeutics, Inc.
  • Oviva Therapeutics, Inc.
  • PanOptica, Inc.
  • PanTher Therapeutics, Inc.
  • Paragon Therapeutics, Inc.
  • Parthenon Therapeutics, Inc.
  • Pathalys Pharma, Inc.
  • Pear Bio
  • PepGen Inc.
  • perForm biologics, inc.
  • Permeasis Therapeutics, Inc.
  • PharmaEssentia USA Corporation
  • Pheon Therapeutics Ltd.
  • Phylaxis Bioscience, LLC
  • PIC Therapeutics, Inc.
  • Pliant Therapeutics, Inc.
  • Potens Animal Health
  • Praeventix, Inc.
  • Prokarium Ltd
  • ProThera Biologics, Inc.
  • Puma Biotechnology, Inc.
  • Q1, Inc.
  • Q2, Inc.
  • QurAlis Corporation
  • Red Arrow Therapeutics, Inc.
  • Rekindle Therapeutics Inc.
  • Relay Therapeutics, Inc.
  • RemeGen Biosciences, Inc.
  • Repertoire Immune Medicines
  • Revalia Bio, Inc.
  • Rgenta Therapeutics, Inc.
  • Rhoshan Pharmaceuticals, Inc.
  • Ribo Therapeutics Inc.
  • Right Brain Bio, Inc.
  • Rila Therapeutics, Inc.
  • RocketVax AG
  • Sage Therapeutics, Inc.
  • Sail Biomedicines, Inc.
  • SalioGen Therapeutics, Inc.
  • Scorpion Therapeutics, Inc.
  • Seismic Therapeutic, Inc.
  • Senda Biosciences, Inc.
  • Severin Therapeutics, Inc.
  • Sieben Therapeutics, Inc.
  • SLAP Pharmaceuticals, LLC
  • Solu Therapeutics, Inc.
  • SonALAsense, Inc.
  • Sonoma Biotherapeutics, Inc.
  • SOTIO Biotech Inc.
  • Souffle Therapeutics
  • Spyre Therapeutics, Inc.
  • Stoke Therapeutics, Inc.
  • STORM Therapeutics Ltd.
  • Strand Therapeutics, Inc.
  • Stylus Medicine, Inc.
  • Sudo Biosciences Inc.
  • Sudo Biosciences Limited
  • Summation Bio, Inc.
  • SURGE Therapeutics, Inc.
  • Synedgen, Inc.
  • Synthego Corporation
  • Tasca Therapeutics Corp.
  • Tavanta Therapeutics, Inc.
  • Tectonic Therapeutic, Inc.
  • Tessera Therapeutics, Inc.
  • TFC Therapeutics, Inc.
  • Theaprin Pharmaceuticals, Inc.
  • Theragnostics Ltd.
  • Thymmune Therapeutics, Inc.
  • TMS Co., Ltd.
  • Torqur AG
  • TransformaTX Biotherapeutics LLC
  • Treadwell Therapeutics, Inc.
  • TScan Therapeutics, Inc.
  • Vernal Biosciences, Inc.
  • Verra Therapeutics, LLC
  • Versatope Therapeutics, Inc.
  • Verseau Therapeutics, Inc.
  • Verve Therapeutics, Inc.
  • Vicore Pharma AB
  • Vigil Neuroscience, Inc.
  • Viridian Therapeutics, Inc.
  • Viridian, LLC
  • viTToria bioTherapeutics, Inc.
  • Volastra Therapeutics, Inc.
  • Volstra Therapeutics
  • Voyager Therapeutics, Inc.
  • Xbiome, Inc.
  • XenImmune Therapeutics, Inc.
  • YZ Advanced CGT Consulting, LLC
  • Zenas BioPharma
  • Zenon Biotech, Inc.
Learn more about our work in this industry

  • Clisertec Corporation
  • Curated Planet, LLC
  • Gleason Technology, Inc.
  • GlobalSign, Inc.
  • GOLDPoint Healthcare, LLC
  • iCapture
  • IQ Proteomics, LLC
  • Liteboxer Technologies, Inc.
  • Micropsi Industries, GmbH
  • Muzooka, Inc.
  • Optera Life Sciences, LLC
  • Parking Edge LLC
  • Transformate, LLC
  • YBRP, Inc.
Learn more about our work in this industry

  • 4D Molecular Therapeutics, Inc.
  • 5AM Venture Management LLC
  • AllerFund Ventures, LLC
  • ARCH Ventures
  • Columbus Venture Partners, SGEIC, SAU
  • CoVenture
  • Delos Advisors Limited
  • Flagship Pioneering
  • GG1978 SICAF SIF
  • GV (Google Ventures)
  • ShangPharma Innovation, Inc.
  • Vesper Biotech Fund I, LP
  • Westlake BioPartners, LLC
Learn more about our work in this industry

Recent transactions

Previous Page
Next Page

TMS Co., Ltd. + JiXing Pharmaceuticals + RTW Investments, LP

Strategic Collaboration Agreements

The firm counseled TMS Co. Ltd. as it entered strategic collaboration agreements with JIXING Pharmaceuticals, subsequent to the assignment of TMS-007 global rights from Biogen to JIXING. TMS regained Japan rights to this compound, received a payment of JIXING equity, and obtained Japan rights to JX09. TMS contemporaneously received a private equity investment from RTW

Press Release
Claris Biotherapeutics, Inc. Logo

Claris Biotherapeutics, Inc.

Series A-3 Preferred Stock Financing

Claris Bio closes latest venture round to bring total financing to roughly $60 million, accelerating its late-stage clinical development of a novel therapeutic agent for neurotrophic keratopathy. Investors include Novo Holdings A/S, RA Capital, Mass General Brigham Ventures, and Janus Henderson Investors

Press Release
GV (Google Ventures) Logo

GV (Google Ventures)

Chroma Medicine Series B Financing

Representation of GV, as lead, ARCH Venture Partners and DCVC in Chroma Medicine’s $135M Series B Financing

Press Release
NextPoint Therapeutics, Inc. Logo

NextPoint Therapeutics, Inc.

Series B Financing - $80 million

NextPoint Therapeutics raises $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi.  Additional new investors in the round include Invus, Catalio Capital Management, Sixty Degree Capital and PagodaTree Partners. Existing investors that took part in the financing include MPM Capital Management and Dana-Farber Cancer Institute

Paragon Therapeutics, Inc. Logo

Paragon Therapeutics, Inc. + Apogee Therapeutics, Inc.

Antibody Discovery and Option Agreement

Option for exclusive development and commercial rights to a suite of Paragon’s top-tier antibodies specifically engineered to target some of the largest and highest unmet needs in inflammatory and immunological conditions

Press Release
6 Dimensions Capital Logo

6 Dimensions Capital

VC Investments

Equity investments in multiple portfolio companies, including Hibercell

Puma Biotechnology, Inc. Logo

Puma Biotechnology, Inc.

Clinical Trial

CRO and Site Agreements for an Open-Label, Phase 2 Study with 30 Sites in 9 Countries exploring the efficiency of Neratinib on Patients with Solid Tumors with Somatic Human Epidermal Growth Factor Receptor (EGFR, HER2, HER3) Mutations Or EGFR Gene Amplification

See Study
Epalex Corporation Logo

Epalex Corporation

Series A-3 Financing

Series A-3 preferred equity financing to continue advancing Epalex’s two clinical-stage development programs

Praeventix, Inc. Logo

Praeventix, Inc.

Private Investment

Private Investment from Tellus BioVentures

Vertex Pharmaceuticals Incorporated Logo

Vertex Pharmaceuticals Incorporated

Acquisition of Private Company

Co-counsel to Vertex on acquisition of ViaCyte, a privately-held biotechnology company that received substantial research funding from the California Institute of Regenerative Medicine

Press Release
Versant Ventures Management, LLC Logo

Versant Ventures Management, LLC

Antibody Discovery and Collaboration Agreement

Multi-year collaboration with AbCellera to discover therapeutic antibodies for multiple targets selected by Versant’s portfolio of biologics-focused biotechnology companies

Press Release
Vizgen, Inc. Logo

Vizgen, Inc.

Series C Financing

Vizgen raises Series C equity funding led by Blue Water Life Science Advisors, LLC, ARCH Venture Fund X, L.P. and other existing investors

Press Release
This site uses cookies. Some provide anonymous analysis of how our website is used and some are essential to make the website work. Other cookies enable personalized services or social media features to be used. By using our website, you agree to the use of cookies. To find out more, please see our Privacy Policy. You can disable cookies at any time by changing your browser settings.